ALTEOGEN Inc. (KOSDAQ:196170)
South Korea · Delayed Price · Currency is KRW 456,500
-62,500 (-12.04%)
At close: Dec 5, 2025
ALTEOGEN Market Cap
ALTEOGEN has a market cap or net worth of 24.41 trillion as of December 5, 2025. Its market cap has increased by 4.83% in one year.
Market Cap
24.41T
Enterprise Value
24.17T
Revenue
202.18B
Ranking
n/a
PE Ratio
201.73
Stock Price
456,500.00
Market Cap Chart
Since December 12, 2014, ALTEOGEN's market cap has increased from 119.96B to 24.41T, an increase of 20,253.00%. That is a compound annual growth rate of 62.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 24.41T | 48.01% |
| Dec 30, 2024 | 16.49T | 221.05% |
| Dec 28, 2023 | 5.14T | 160.78% |
| Dec 29, 2022 | 1.97T | -38.41% |
| Dec 30, 2021 | 3.20T | -36.62% |
| Dec 30, 2020 | 5.05T | 442.81% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 75.96T |
| Celltrion | 40.11T |
| ABL Bio | 10.51T |
| SK Biopharmaceuticals | 10.49T |
| Yuhan | 8.76T |
| LigaChem Biosciences | 6.75T |
| Peptron | 6.65T |
| HLB Co., Ltd. | 6.46T |